AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Imeglimin Hydrochloride 500 Mg ;

9 registrations across 1 African market— 9 active

Markets with Imeglimin Hydrochloride 500 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Imeglispire
Film Coated Tablets
🇪🇬EgyptPROTECH PHARMACEUTICAL COMPANYactive
Vantaglimin 500 mg
Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active
Imegetic
Film Coated Tablets
🇪🇬EgyptUtopia pharmaceuticalsactive
Imeglibright
Film Coated Tablets
🇪🇬EgyptAL ESRAA PHARMACEUTICAL OPTIMA-EGYPTactive
Imeglispire
Film Coated Tablets
🇪🇬EgyptPROTECH PHARMACEUTICAL COMPANYactive
Glimcoza 500 mg
Film Coated Tablets
🇪🇬EgyptATCO Pharma for Pharmaceutical Industriesactive
Imegetic
Film Coated Tablets
🇪🇬EgyptUtopia pharmaceuticalsactive
Imeglibright
Film Coated Tablets
🇪🇬EgyptAL ESRAA PHARMACEUTICAL OPTIMA-EGYPTactive
Vantaglimin 500 mg
Film Coated Tablets
🇪🇬EgyptZeta Pharma for Pharmaceutical Industries (Zeta Pharma)active

Imeglimin Hydrochloride 500 Mg ; in Africa — Regulatory Overview

Imeglimin Hydrochloride 500 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.